Belite Bio, Inc (NASDAQ:BLTE) Q1 2026 Earnings Call Transcript May 20, 2026
Belite Bio, Inc beats earnings expectations. Reported EPS is $-0.34, expectations were $-0.6.
Operator: Ladies and gentlemen, thank you for joining us, welcome to the Belite Bio first Quarter 26 Earnings Call. After today’s prepared remarks, we will host a question-and-answer session. If you would like to ask a question, please raise your hand. If you have dialed in to today’s call, please press 9 to raise your hand....
